How to Read a Methacholine Challenge Test
A methacholine challenge test is positive when FEV1 falls ≥20% from baseline, with the PC20 (provocative concentration causing 20% FEV1 decline) serving as the primary quantitative measure of airway hyperresponsiveness. 1, 2
Core Interpretation Criteria
Positive Test Definition
The test is definitively positive when:
- FEV1 decreases ≥20% from the post-diluent baseline value at any methacholine concentration up to 16 mg/mL 1, 2
- The patient develops obvious wheezing symptoms or audible wheezing on lung auscultation, even if FEV1 decline is between 10-20% 3
PC20 Calculation
Calculate PC20 using logarithmic interpolation between the last two concentrations:
PC20 = antilog [log C1 + (log C2 - log C1)(20 - R1)/(R2 - R1)]
Where:
- C1 = second-to-last methacholine concentration (before reaching 20% fall)
- C2 = final concentration (causing ≥20% fall in FEV1)
- R1 = % fall in FEV1 after C1
- R2 = % fall in FEV1 after C2 1, 2
Critical technical point: Use the highest acceptable FEV1 value at each dose level, measured at 30 and 90 seconds post-inhalation 1
Categorization of Bronchial Hyperresponsiveness
Interpret PC20 values according to this standardized classification:
| PC20 (mg/mL) | Interpretation |
|---|---|
| >16 | Normal bronchial responsiveness (negative test) |
| 4.0-16 | Borderline BHR |
| 1.0-4.0 | Mild BHR (positive test) |
| <1.0 | Moderate to severe BHR |
This classification only applies when:
- Baseline airway obstruction is absent (FEV1 ≥60% predicted)
- Spirometry quality meets standards
- Substantial post-bronchodilator FEV1 recovery occurs 1
Critical Interpretation Factors
Pre-Test Considerations That Modify Results
Always evaluate these factors before finalizing interpretation:
- Pretest probability of asthma based on current symptoms
- Baseline FEV1 - lower values increase false positive risk
- Quality of spirometry maneuvers - poor technique invalidates results
- Medication washout adequacy - inadequate washout causes false negatives
- Recent respiratory infections (<4 weeks) - increase false positives
- Smoking status - smokers have higher baseline hyperresponsiveness 1, 2
Negative Test Reporting
If FEV1 does not fall ≥20% after the highest concentration (16 mg/mL):
- Report as "PC20 >16 mg/mL"
- Never extrapolate beyond the final concentration tested 1
If FEV1 falls ≥20% after diluent alone:
- Do not report a PC20
- State: "Significant decrease in lung function after diluent inhalation; methacholine was not administered" 1
Common Pitfalls and Caveats
False Negatives Occur When:
- Insufficient medication washout - β2-agonists (12-48 hours), anticholinergics (24-48 hours), inhaled corticosteroids (variable effect)
- Exercise-induced asthma - may require indirect challenge tests (exercise, cold air, hyperventilation) rather than methacholine 3
- Poor inhalation technique - inadequate methacholine delivery
- Equipment malfunction - incorrect nebulizer output or particle size 3
False Positives Occur With:
- Allergic rhinitis without asthma
- Recent viral upper respiratory infections (<4 weeks)
- Chronic obstructive pulmonary disease
- Smoking or recent air pollution exposure
- Other conditions: cystic fibrosis, sarcoidosis, bronchiectasis, congestive heart failure 1, 2, 3
Key clinical principle: A positive methacholine test does not equal asthma diagnosis - it confirms airway hyperresponsiveness, which requires clinical correlation 1, 4
Suspiciously Positive Results
When FEV1 decreases 15-20% without dyspnea or wheezing:
- Report as "suspiciously positive"
- Consider repeating test after addressing confounding factors
- Correlate with clinical presentation before diagnosing asthma 3
Safety Monitoring During Testing
Stop the test immediately and administer bronchodilators when:
- FEV1 falls ≥20% from baseline
- Patient develops significant respiratory symptoms (wheezing, dyspnea, chest tightness)
- Audible wheezing on auscultation, regardless of FEV1 change 1, 3
Post-test recovery protocol:
- Administer 200-400 μg salbutamol (or equivalent SABA)
- Reassess FEV1 after 5-10 minutes
- Patient cannot leave until FEV1 recovers to within 90% of baseline 2, 3
Alternative Dosing Metrics
For the APS method (quantitative nebulization):
- PD20 (provocative dose) shows better consistency across different protocols than PC20
- Threshold value: PD20 of 2.5 mg indicates significant hyperresponsiveness 3
For the Astograph method (forced oscillation):
- Uses Dmin (minimum cumulative dose causing linear increase in respiratory resistance)
- Dmin ≤6 Units suggests high likelihood of asthma
- Dmin 6-10 Units requires further differential diagnosis 3